![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Regeneron Drugs Show Favorable Signs in Trials
Regeneron Drugs Show Favorable Signs in Trials
May 12, 2010
Regeneron Pharmaceuticals’ experimental drugs to cut cholesterol and treat osteoarthritis showed strong signs of effectiveness in early-stage trials, the biotechnology company said on Wednesday.
CNBC
CNBC
Upcoming Events
-
21Oct